Search Results

Debate: Adjuvant EGFR-directed therapy for patients with early stage NSCLC? - No

Debate: Adjuvant EGFR-directed therapy for patients with early stage NSCLC? - No

Debate: Adjuvant EGFR-directed therapy for patients with early stage NSCLC? - Yes

Debate: Adjuvant EGFR-directed therapy for patients with early stage NSCLC? - Yes

Drs. Sepesi & Cascone discuss EGFR-targeted therapy in early-stage NSCLC: https://bit.ly/3oZllfo

Drs. Sepesi & Cascone discuss EGFR-targeted therapy in early-stage NSCLC: https://bit.ly/3oZllfo

Multimodal Management of Early-Stage NSCLC: EGFR-Targeted Therapy in Perioperative Settings

Multimodal Management of Early-Stage NSCLC: EGFR-Targeted Therapy in Perioperative Settings

Precision Oncology in Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way

Precision Oncology in Early-Stage Lung Cancer, With Adjuvant EGFR-Targeted Therapy Leading the Way

Adjuvant EGFR-Targeted Therapy as a Game Changer in Multimodal NSCLC Management

Adjuvant EGFR-Targeted Therapy as a Game Changer in Multimodal NSCLC Management

Adjuvant therapy for Early Stage Lung Cancer – Case Based Discussion for Patient with Stage 1B NSCLC

Adjuvant therapy for Early Stage Lung Cancer – Case Based Discussion for Patient with Stage 1B NSCLC

Debate: Adjuvant therapy for resected node negative stage I NSCLC? - Never

Debate: Adjuvant therapy for resected node negative stage I NSCLC? - Never

Adjuvant EGFR TKI Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Curren...

Adjuvant EGFR TKI Therapy in Patients With Completely Resected Non-Small-Cell Lung Cancer: Curren...

Adjuvant therapy for EGFR mutant NSCLC

Adjuvant therapy for EGFR mutant NSCLC

Debate: Adjuvant therapy for resected node negative stage I NSCLC? - Sometimes

Debate: Adjuvant therapy for resected node negative stage I NSCLC? - Sometimes

EGFR Inhibitors as Adjuvant Therapy in NSCLC

EGFR Inhibitors as Adjuvant Therapy in NSCLC